Accretion Pharmaceuticals Limited IPO

Accretion Pharmaceuticals IPO

[{"selector":"#anim-d3a3ced7-23ee-4a88-833c-394722f6ad6f [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-25.362499850500598%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-8de8453a-db05-40ed-9e81-6c7989a5c3b2","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e1ba8198-2b53-4538-8f0f-79902eccdb70","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-70cb8486-7c30-4e98-9278-f1efb136d836","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-716c3a12-7349-4ddb-8970-7bc57a38d94f","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Accretion Pharma's IPO offers 29.46L shares (₹29.75 Cr) to fund machinery, debt repayment, working capital, and other corporate needs. Read more

Important Details

[{"selector":"#anim-eedd0420-c25f-4f76-b7a5-210f72e0b990 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.24062488616884%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-894a196f-3ff8-4d49-85da-d8c4ac863991","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e7d35c24-3b66-46a5-9aae-f28c366fd070","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3ed0dfe8-89ed-46d9-aa18-942ebafa2ad3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6f98368b-fd2c-4240-a7cd-88a37b96e351","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Open Date : May 14, 2025 Close Date :May 16, 2025 Allotment Date: May 19, 2025 Listing Date: May 21, 2025 Important Details

Important Details

[{"selector":"#anim-51c04508-1de1-4239-bbff-5aac6e33a034 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-22.77499983479975%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-748aca9d-007f-4422-bd46-70678ea5e837","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9cddd26a-44f3-4ced-a4a2-5311054044ab","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b473d8b8-570e-468c-9897-c074e321b19c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ef0f054e-aff9-44b2-8145-0f66560fb2b2","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] IPO Price: INR 96-101 per share Lot Size: 1200 Shares. Total Issue Size: INR 29.75 crores Important Details

Fundamental Analysis

[{"selector":"#anim-1750f11d-772c-4e37-820e-4e48af270f47 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.24062488616884%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-8a6d7b49-6c97-45e2-817d-30685e55eb8c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d1dcc388-b35c-4a61-910e-8098e5831903","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a739b96f-0088-473d-800b-3b6cd1894d9b","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a867e022-9fbd-4f9a-844b-d64614ace452","keyframes":{"transform":["translate3d(114.87342%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Accretion Pharmaceuticals IPO shows mixed performance: 1. Strong Revenue and profit growing. 2. Assets and liquidity improved. 3. Increased debt-equity ratio, raising concerns. Fundamental Analysis

Peer Comparison

[{"selector":"#anim-f462582a-1e4c-4ee5-88b0-48df7a071580 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-31.21249988599818%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-b02de828-fdcd-4a4f-8b8a-9ccb4597c311","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f325f872-99c8-463b-baf8-3cc7ec68684e","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2d00be46-1110-427f-8796-c29f87d8cc22","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f93a8cad-e671-4242-a2c1-48428523518a","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Accretion Pharmaceuticals IPO Peer Comparison: 1. Accretion Pharma : High RoNW. 2. Sakar Healthcare : Best P/E ratio. 3. Lincoln Pharma : shows strong revenue. 4. Sotac Pharma : Steady growth. Peer Comparison

Objective

[{"selector":"#anim-7b52f9b0-9152-48a7-956a-296c5bcf9993 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-21.874999829338588%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-d99aaad7-417f-4bbd-abad-55cc37a45e4e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c5bbf010-8417-4767-a000-93afcfb86490","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c8a6871e-49d5-40bf-a92a-3fbe0f31f1ee","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0093c67c-4358-4848-b37a-8d3a505d1db5","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Accretion Pharmaceuticals IPO Objective: 1. Fund machinery & equipment purchase. 2. Repay/prepay borrowings. 3. Support working capital & general corporate purposes. Objective

Risks And Challenges

[{"selector":"#anim-935b52f3-9cfb-4bd9-918a-9e8029a9300e [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-28.90624987200394%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-dce7717d-c188-4e9b-8ad0-d7b38fad1bc7","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8b8c0bc5-303b-4a83-9116-7d20a0339dea","keyframes":{"transform":["translate3d(-115.8576%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-75d2c6d2-9c03-40ec-bbc8-12101d24827b","keyframes":{"opacity":[0,1]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fd48e1c7-9fdf-43d3-a263-47e3f36d09bc","keyframes":{"transform":["translate3d(115.18987%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1200,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Accretion Pharmaceuticals IPO Risks: 1. High reliance on export revenue. 2. Strict pharma regulatory compliance. 3. Risk of regulatory actions affecting operations and profits. Risks And Challenges

Check Out More IPO Review Articles

[{"selector":"#anim-bdb2899c-4489-4222-8430-5760d21b9188 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-44.24337496767666%, 0, 0) translate(-25%, 0%) scale(1.5)","translate3d(0%, 0, 0) translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"fill":"forwards"}] [{"selector":"#anim-b7e13dac-f2b6-414b-9054-af7ffe937413","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-de884625-cd83-4f4e-b0bd-4def55e0fd07","keyframes":{"transform":["translate3d(101.50377%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-edac61a8-0710-4152-af90-1f6bd5c66ff3","keyframes":{"opacity":[0,1]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a7dcbe94-dfc7-425f-a3bc-cd26f1e73bb7","keyframes":{"transform":["translate3d(67.50000%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-486ff031-1eb8-47cb-9622-685845077ed6","keyframes":{"transform":["translate3d(-133.61345%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-86f7e59f-d1e2-4d5d-9f5d-3f2e548870bd","keyframes":{"transform":["rotateZ(-180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}] [{"selector":"#anim-4cdb4889-3c60-4894-91fd-beebc7ee17e3","keyframes":{"transform":["translate3d(119.59459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-54a39a1b-8ebe-4469-a975-526dace9c49a","keyframes":{"transform":["rotateZ(180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}] [{"selector":"#anim-b8b8cf95-17a5-4a0c-ad23-9e50d94d4207","keyframes":{"transform":["translate3d(-119.59459%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .8, 1)","fill":"both"}] [{"selector":"#anim-f6526229-b418-4c86-b7bb-919160444ae6","keyframes":{"transform":["rotateZ(-180deg)","rotateZ(0deg)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(.2, 0, .5, 1)","fill":"forwards"}] Disclaimer *T&C Apply Open Account Now!